MedPath

Efficacy of Navaka Kashaya and Manjisthadi Tail in the management of dry eczema.

Phase 2
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2023/07/054863
Lead Sponsor
ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients age between 18-60 years

Patients of either sex

Patients having any signs and symptoms of Vicharchika (Eczema) like Vaivarnyata (Discolouration) Rukshata (Dryness) Kandu (pruritis) Rajii (Thickening of skin)

Patients having chronicity less than 5 years

Exclusion Criteria

Patients with Steroid and cytotoxic treatment( >5 years).

Patient having concomitant illness( like-HIV, Malignancy, any immuno-compromised state.)

patient having associated skin disease like-vitiligo, psoriasis etc.)

Pregnant or lactating women

Patient participated in any clinical trial for last 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the EASI ScoreTimepoint: 42 Days
Secondary Outcome Measures
NameTimeMethod
Change in Sign and Symptoms of Vicharchika with special reference to Dry Eczema andChange in the Extent of impairment in QoL by using DLQI(Dermatology Life Quality Index). <br/ ><br>Timepoint: Baseline and 42 days after treatment.
© Copyright 2025. All Rights Reserved by MedPath